Mechanistically, TGFBI propels cancer progression by activating αvβ5 integrin signaling, ultimately engaging Src, FAK, PI3K, and AKT through its RGD motif, as observed in models of osteosarcoma, colon, and pancreatic cancer12,14,15. This evidence concerns the gene PTK2 and cancer.